HKEX Stock Code: 01093English|繁體|简体
Home > Investor Relations > Announcements & Notices
Announcements & Notices
May
27
INSIDE INFORMATION - PROPOSED ISSUE OF RMB SHARES OR CHINESE DEPOSITARY RECEIPTS AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE
May
27
QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2020
May
19
VOLUNTARY ANNOUNCEMENT - "DOCETAXEL FOR INJECTION (ALBUMIN-BOUND)" OBTAINS CLINICAL TRIAL APPROVAL
May
15
DATE OF BOARD MEETING
May
04
VOLUNTARY ANNOUNCEMENT - "ORNITHINE ASPARTATE INJECTION" OBTAINS DRUG REGISTRATION APPROVAL
Apr
27
NOTICE OF ANNUAL GENERAL MEETING
Apr
26
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2020
Mar
30
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2019
Mar
22
INSIDE INFORMATION - INDICATIVE RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2020
Mar
22
INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019
Mar
18
DATE OF BOARD MEETING
Mar
09
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "RIVAROXABAN TABLETS"
Feb
25
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "MONTELUKAST SODIUM TABLETS AND CHEWABLE TABLETS"
Feb
24
INSIDE INFORMATION - PRELIMINARY RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019
Feb
24
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG ALMB-0168 WAS GRANTED CLINICAL TRIAL APPROVAL IN AUSTRALIA
Jan
22
INSIDE INFORMATION - INDICATIVE RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2019
Jan
19
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT
Jan
02
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "PRAMIPEXOLE DIHYDROCHLORIDE TABLETS"
Jan
02
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "SUNITINIB MALATE CAPSULES"

Please download the latest "Acrobat Reader" to view the PDF.

© Copyright 2020 CSPC Pharmaceutical Group Limited. All Rights Reserved.
Disclaimer